KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) EPS (Weighted Average and Diluted) (2016 - 2025)

Elevance Health (ELV) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $2.56 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 36.9% to $2.56 in Q4 2025 year-over-year; TTM through Dec 2025 was $25.21, a 1.79% decrease, with the full-year FY2025 number at $25.21, down 1.83% from a year prior.
  • EPS (Weighted Average and Diluted) was $2.56 for Q4 2025 at Elevance Health, down from $5.32 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $9.85 in Q2 2024 to a low of $1.87 in Q4 2024.
  • A 5-year average of $6.27 and a median of $6.7 in 2021 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 604.6% in 2021, then crashed 49.18% in 2024.
  • Elevance Health's EPS (Weighted Average and Diluted) stood at $4.86 in 2021, then fell by 25.72% to $3.61 in 2022, then grew by 1.94% to $3.68 in 2023, then plummeted by 49.18% to $1.87 in 2024, then skyrocketed by 36.9% to $2.56 in 2025.
  • Per Business Quant, the three most recent readings for ELV's EPS (Weighted Average and Diluted) are $2.56 (Q4 2025), $5.32 (Q3 2025), and $7.72 (Q2 2025).